Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials

Published:2023-04 Issue:2 Volume:10 Page:150-160
ISSN:2095-7548
Container-title:Journal of Traditional Chinese Medical Sciences
language:en
Short-container-title:Journal of Traditional Chinese Medical Sciences

Author:

Xu Jing^ORCID,Wu Kang,Li Xiao,Teo Chiah Shean^ORCID,Li Guangda,Pan Yiming,Hou Li

Funder

National Natural Science Foundation of China

Capital Health Research and Development of Special Fund

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference46 articles.

1. Management of anemia in cancer patients;Calabrich;Future Oncol,2011

2. Treatment of anemia in patients with solid tumors receiving chemotherapy in palliative setting: usual practice versus guidelines;Putter;Acta Clin Belg,2018

3. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients;Ludwig;Eur J Cancer,2004

4. Prevalence and treatment of cancer-related anemia: a nationwide survey in China;Song;China Cancer,2019

5. Efficacy and cardiovascular adverse effects of erythropoiesis stimulating agents in the treatment of cancer-related anemia: a systematic review of randomized controlled trials;Rao;Cureus,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP